Experts say federal action on medical tort reform still unlikely

Despite a Republican president and Congress, tort reform still faces an uphill battle in the Senate.

While various states have taken action to control medical malpractice insurance rates, efforts to pass federal reforms to cap noneconomic damages in lawsuits have repeatedly failed—and experts say that’s unlikely to change.

Despite the shift in Washington where Republicans now control the House, Senate and White House, federal tort reform will still face an uphill battle, according to Physicians Practice.

While off the table in Congress for a few years, some proposed bills would introduce tort reform again, Mike Stinson, vice president of government relations at the Physician Insurers Association of America, told the publication. But the Senate, where efforts in the past have failed to get the 60 votes needed to overcome a filibuster, will still be reluctant, he said.


2019 Drug Pricing and Reimbursement Stakeholder Summit

Given federal and state pricing requirements arising, press releases from industry leading pharma companies, and the new Drug Transparency Act, it is important to stay ahead of news headlines and anticipated requirements in order to hit company profit targets, maintain value to patients and promote strong, multi-beneficial relationships with manufacturers, providers, payers, and all other stakeholders within the pricing landscape. This conference will provide a platform to encourage a dialogue among such stakeholders in the pricing and reimbursement space so that they can receive a current state of the union regarding regulatory changes while providing actionable insights in anticipation of the future.

Katie Orrico, director of the Washington office of the American Association of Neurological Surgeons, would like to see action, but agreed with Stinson it is unlikely.

"Our biggest roadblock has always been the Senate, and I think this year will be no different, unfortunately," Orrico told the publication. Orrico also serves as the vice chair of the Health Coalition on Liability and Access, an advocacy coalition that works to enact medical liability reform at the national level

RELATED: Leading Republicans see a costly malpractice crisis—experts don’t

Malpractice insurance rates are still high but have stabilized.

However, many physician advocacy groups would still like to see Congress pass a law capping noneconomic damages at $250,000. With the election of Donald Trump as president and the appointment of Tom Price—an orthopedic surgeon who as a congressman made liability reform a priority—as secretary of the Department of Health and Human Services, those groups have been more optimistic.

However, one bill, the Protecting Access to Care Act, which is modeled after successful reforms in California and that would cap legal damages, has lawyers and doctors squaring off.

RELATED: Lawyers, doctors square off over tort reform bill

While the American College of Physicians sees the bill as likely to reduce costs associated with what White House Press Secretary Sean Spicer termed “frivolous lawsuits,” lawyers and Democratic lawmakers said it will make it more difficult for those injured by medical devices, drugs or malpractice to receive full compensation.

One big advantage to have uniform malpractice laws across the states is the expanded use of telemedicine, which allows doctors to treat patients in different states where liability laws may be different, Stinson said

Suggested Articles

CMS Administrator Seema Verma said it will be crucial to have more conversations on how to address emerging—and expensive—therapies. 

We need our federal programs and policies to reflect the goal of improving the health of both women and men.

The political jockeying over "Medicare for All" continued Wednesday as a House committee hosted a second hearing on single-payer healthcare.